|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.9XXS |
Unspecified complication of internal prosthetic device, implant and graft, sequela
|
T859XXS utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 18.32%
|
26.24%
|
15.84%
|
13.86%
|
9.41%
|
5.94%
|
1.49%
|
0.50%
|
0.99%
|
0.99%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.9XXS*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
22
|
22
|
|
G0467
|
FQHC VISIT, ESTAB PT |
8
|
8
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
7
|
7
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6
|
6
|
|
80048
|
METABOLIC PANEL TOTAL CA |
6
|
6
|
|
99308
|
SBSQ NF CARE LOW MDM 20 |
5
|
5
|
|
97110
|
THERAPEUTIC EXERCISES |
3
|
7
|
|
87086
|
URINE CULTURE/COLONY COUNT |
2
|
2
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2
|
2
|
|
G1004
|
CDSM NDSC |
2
|
2
|
|
86160
|
COMPLEMENT ANTIGEN |
2
|
2
|
|
85652
|
RBC SED RATE AUTOMATED |
2
|
2
|
|
88300
|
SURGICAL PATH GROSS |
2
|
2
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
2
|
2
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
2
|
12
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
2
|
2
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
2
|
8
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2
|
2
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2
|
140
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
2
|
6
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.9XXS related to the following DRG Codes:
922-923
|
